Synaptic loss is present in Alzheimer's disease and correlates with the severity of dementia. Loss of synapses in dementia with Lewy bodies (DLB) does not correlate as clearly with cognitive status and its cause is unclear. To begin to understand the relationship between cognition and synaptic loss in DLB, we assessed immunoreactivity for the synaptic-terminal specific protein, synaptophysin, in the hippocampus in 14 DLB cases. Quantitative synaptic data were obtained using an Image-Pro semiautomated analysis system. We determined Braak stage, β-amyloid, Lewy bodies (LBs), and Lewy neurites (LN). We found significant correlations (r = 0.617, P < .01) between Braak stage and synaptophysin score and marginal correlation between LN score and synaptophysin loss ( r = 0.694, P < .06). Correlations of β-amyloid and of LB density with synaptophysin score were unimpressive. These data support the hypothesis that synaptic loss in DLB is related to neuritic degeneration.
McKeith IG, Galasko D., Kosaka K., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113-1124.
2.
Marui W., Iseki E., Kato M., Akatsu H., Kosaka K.Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease. Acta Neuropathol. 2004 ;108: 121-128.
3.
Merdes AR, Hansen LA, Jeste DV, et al. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology. 2003 ;60: 1586-1590.
4.
McKeith IG, Dickson DW, Lowe J., et al. Consortium on DLB. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology . 2005;65:1864-1872.
5.
Hamos JE, DeGennaro LJ, Drachman DASynaptic loss in Alzheimer's disease and other dementias. Neurology. 1989;39:355-361.
6.
Terry RD, Masliah E., Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30:572-580.
7.
Hansen LA, Daniel SE, Wilcock GK, Love S.Frontal cortical synapthophysin in Lewy body diseases: relation to Alzheimer's disease and dementia. J Neurol Neurosurg Psychiatry. 1998;64:653-656.
8.
Brown DF, Risser RC, Bigio EH, et al. Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging. J Neuropathol Exp Neurol. 1998;57:955-960.
9.
Hamos JE, DeGennaro LJ, Drachman DASynaptic loss in Alzheimer's disease and other dementias. Neurology. 1989;39:355-361.
10.
Lippa CF, Hamos JE, Pulaski-Salo D., DeGennaro LJ, Drachman DAAlzheimer's disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol Aging. 1992;13:405-411.
11.
Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., Del Tredici K.Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl) . 2006; 112:389-404.
12.
Brown DF, Dababo MA, Bigio EH, et al. Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease. J Neuropathol Exp Neurol.1998; 57:39-46.
13.
Popescu A., Lippa CF, Lee VM, Trojanowski JQLewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Arch Neurol. 2004;61:1915-1919.
14.
Lippa CF, Pulaski-Salo D., Dickson DW, Smith TWAlzheimer's disease, Lewy body disease and aging: a comparative study of the perforant pathway. J Neurol Sci. 1997;147:161-166.
15.
Samuel W., Alford M., Hofstetter R., Hansen L.Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. J Neuropathol Exp Neurol. 1997;56:499-508.
16.
Kowalska A.The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease. Neurol Neurochir Pol. 2004;38: 405-411.
17.
Klucken J., McLean PJ, Gomez-Tortosa E., Ingelsson M., Hyman BTNeuritic alteration and neural system dysfunction in Alzheimer's disease and dementia with Lewy bodies. Neurochem Res. 2003;28:1683-1691.
18.
Hashimoto M. , Masliah E.Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies. Neurochem Res. 2003; 28:1743-1756.
19.
Masliah E., Mallory M., DeTeresa R., Alford M., Hansen L.Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies. Brain Res. 1993;617:258-266.
20.
Coleman P., Federoff H., Kurlan R.A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology. 2004;63:1155-1162.
21.
Deramecourt V., Bombois S., Maurage CA, et al. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol.2006;65:278-288.
